BIOMAT Database Logo BIOMAT Database Logo

[Insulin responses to cardiopulmonary bypass (author's transl)]. 1978

H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Clinical experience of pulsatile cardiopulmonary bypass (author's transl)].
January 1979, Kyobu geka. The Japanese journal of thoracic surgery,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Clinical evaluation on pulsatile cardiopulmonary bypass (author's transl)].
November 1981, Kyobu geka. The Japanese journal of thoracic surgery,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
Microvascular responses to cardiopulmonary bypass.
August 1999, Journal of cardiothoracic and vascular anesthesia,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Postoperative care after severe hemodilution in cardiopulmonary bypass (author's transl)].
October 1978, Kyobu geka. The Japanese journal of thoracic surgery,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Effect of pulsatile cardiopulmonary bypass on renal function (author's transl)].
February 1982, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Effect of cardiopulmonary bypass on serum digoxin concentration (author's transl)].
January 1976, L'Ateneo parmense. Acta bio-medica : organo della Societa di medicina e scienze naturali di Parma,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Optimal left ventricular filling pressure after cardiopulmonary bypass (author's transl)].
April 1981, Herz,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Plasma catecholamine responses to cardiopulmonary bypass].
December 1986, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Some problems of prostaglandin E1 administration during cardiopulmonary bypass (author's transl)].
January 1980, Kyobu geka. The Japanese journal of thoracic surgery,
H Yokota, and K Kawashima, and T Mori, and S Hashimoto, and H Tanako
[Effects of prostaglandin I2 infusion during experimental cardiopulmonary bypass (author's transl)].
February 1982, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
Copied contents to your clipboard!